assess squamou cell carcinoma antigen scc marker epidermoid carcinoma anal canal squamou cell carcinoma antigen scc epidermoid carcinoma anal canal patient sampl diagnosi treatment follow-up sampl posit threshold ng/ml diagnosi sensit marker percent specif percent seri pretherapeut level scc papillon clinic stage system nodal invas prognost valu time diagnosi follow-up relaps level scc ng/ml increas signific sensit marker percent patient develop ill level scc prognost valu conclus level scc clinic follow-up patient epidermoid carcinoma anal canal 